Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Disease Area Cell & gene therapy

The Genomic Revolution

| Stephanie Sutton

Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views.

Tools & Techniques Clinical trials

The SCOPE of Things to Come

It is your responsibility to encourage patients to join the SCOPE study

Tools & Techniques Analytical science

Expanding the Anti-Cancer Arsenal

We quizzed Amanda about her contribution to the fight against cancer – and life outside the lab

Register to personalize your newsfeed

Create Account

Latest Articles

Tools & Techniques Diagnostics & prognostics

Catching Stroke Early with Blood-Based Testing

| Olivia Gaskill

Blood biomarkers specific to brain damage may help identify early signs of stroke

Research Field Genetics

New Meta-DNA Structures for DNA Origami

A new type of meta-DNA structure promises transformation in the fields of optoelectronics and synthetic biology

Disease Area Neurological

The Night Watch

| Phoebe Harkin

Understanding retinal adaptation in photoreceptor degenerative diseases could inspire future treatments

Disease Area Neurological

Solving the RPE Puzzle

Sitting Down With… Luminita Paraoan, University of Liverpool, UK

Disease Area Cancer

Resolve Cancer

| Sponsored by 10x Genomics

Unravel the complexity of cancer biology and reveal insights to advance human health

Disease Area Cell & molecular biology

Protein Expression In Neurogenesis: Right Place, Right Time?

| Olivia Gaskill

Phf21b, a protein associated with intellectual disability and depression, plays a crucial role in neurogenesis.

Disease Area Drug discovery

Transgenic Drug Discovery

| Stephanie Sutton

A breakthrough in transgenic mice opens the door to “Humabodies.”

Tools & Techniques Analytical science

(Prote)omics in Next-Gen Drug Development

| Mark Rogers

Omics fields will play a key role in the quest for personalized medicine

Tools & Techniques Analytical science

The Mass Spec COVID Check

| Maarten Dhaenens

MS could be key to improving COVID-19 testing accuracy and capacity

Research Field Clinical trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

All Articles


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register